See today's BioWorld MedTech
To read the full article sign up for free or sign in.

FDA urges makers of tests marketed under COVID-specific policies to waste no time

March 31, 2023
By Mark McCarty
With the public health emergency for the COVID-19 pandemic rapidly winding down, the U.S. FDA has published guidance for the transition of COVID-specific diagnostic tests and other articles to conventional premarket review mechanisms.
BioWorld MedTech Regulatory Coronavirus U.S. FDA